Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:MG 22:1(13Z)/0:0/0:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003896 AN006399 Postprandial Plasma Metabolomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Cardiovascular disease Nanjing Medical University Other
ST003896 AN006399 Postprandial Plasma Metabolomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Diabetes Nanjing Medical University Other
ST003896 AN006399 Postprandial Plasma Metabolomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal Blood Human Obesity Nanjing Medical University Other
ST003895 AN006398 Postprandial Plasma Metabolomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Cardiovascular disease Nanjing Medical University Other
ST003895 AN006398 Postprandial Plasma Metabolomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Diabetes Nanjing Medical University Other
ST003895 AN006398 Postprandial Plasma Metabolomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients Blood Human Obesity Nanjing Medical University Other
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Human Cancer Universitätsspital Zürich MALDI-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Mouse Cancer Universitätsspital Zürich MALDI-MS
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic LC-MS
  logo